Table 1 Characteristics of the patients in the AH and H group
AH group | H group | P value | ||
|---|---|---|---|---|
Total number (patients/implants) | 13/34 | 22/43 | – | |
Women (patients/implants) | 5/16 | 16/31 | 0.025* | |
Age (mean), year | 66.7 ± 9.0 | 65.6 ± 10.0 | ns | |
Implant site (maxilla/mandibular) | 21/13 | 14/29 | 0.011* | |
Mean maintenance duration | 6 years and 10 months | 7 years and 3 months | ns | |
Type of implants (patients/implants) | ||||
Nobel ReplaceTM Select implant system | 3/8 | 5/11 | ||
Nobel ReplaceTM Groovy | 6/17 | 12/25 | ||
Brånemark system® Mk III | 4/9 | 5/7 | ||
Antihypertensive medication (patients/implants: running number) | ||||
Calcium antagonists | 6/19 | – | ||
Angiotensin II receptor blockers | 8/18 | – | ||
Beta-blockers | 0/0 | – | ||
Thiazide diuretics | 1/2 | – | ||